Kiora Pharmaceuticals Inc
KPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001372514
No open-market purchases or sales by Kiora Pharmaceuticals Inc insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $2.91M in total; no superinvestor holds it.
Other share classesKPHMW
Q4 2022 vs. Q3 2022
How the institutions holding Kiora Pharmaceuticals Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 9 | 11 | +2 |
| Shares | 34.1K | 151.2K | +117.1K (+343.4%) |
| Value | $209.0K | $518.8K | +$309.8K (+148.2%) |
New holders (4)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Walleye Capital LLC | 83,300 | $285.7K | 0.01% |
| Warberg Asset Management LLC | 33,000 | $113.2K | 0.03% |
| Boothbay Fund Management, LLC | 11,679 | $40.1K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,276 | $15.0K | 0.00% |
Sold out (2)
Institutions that held Kiora Pharmaceuticals Inc at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Geode Capital Management, LLC | 14,008 | $86.0K |
| Spartan Fund Management Inc. | 1,000 | $6.00K |